Drug Shortage Report for VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP

Last updated on 2022-08-04 History
Report ID 166158
Drug Identification Number 02139383
Brand name VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP
Common or Proper name VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) VANCOMYCIN
Strength(s) 1G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 20 mL
ATC code J01XA
ATC description OTHER ANTIBACTERIALS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2022-07-18
Estimated end date 2022-09-01
Actual end date
Shortage status Actual shortage
Updated date 2022-08-04
Company comments Fresenius Kabi Canada regrets to advise that due to further shipping delays, we will be extending the backorder on our Vancomycin Hydrochloride for Injection, USP 1 g SD Vial 20 mL until September 1, 2022. Sterimax is an alternate supplier for Vancomycin Hydrochloride for Injection and have been informed of our impending supply interruption.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2022-08-04 French Compare
v1 2022-08-04 English Compare

Showing 1 to 2 of 2